220 related articles for article (PubMed ID: 8136704)
1. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
[TBL] [Abstract][Full Text] [Related]
2. Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity.
Balwierczak JL; Kukkola PJ; Savage P; Jeng AY
Biochem Pharmacol; 1995 Jan; 49(3):291-6. PubMed ID: 7857315
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats.
Gulati A; Singh R; Chung SM; Sen AP
J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515
[TBL] [Abstract][Full Text] [Related]
5. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.
Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006
[TBL] [Abstract][Full Text] [Related]
6. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.
McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
[TBL] [Abstract][Full Text] [Related]
8. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.
Trapani AJ; De Lombaert S; Kuzmich S; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S69-71. PubMed ID: 8587471
[TBL] [Abstract][Full Text] [Related]
10. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
Held HD; Raschak M; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301
[TBL] [Abstract][Full Text] [Related]
11. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.
McMahon EG; Palomo MA; Moore WM
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358
[TBL] [Abstract][Full Text] [Related]
12. Diuretic-natriuretic actions and pressor effects of big-endothelin (1-39) in phosphoramidon-treated rats.
Hoffman A; Haramati A; Dalal I; Shuranyi E; Winaver J
Proc Soc Exp Biol Med; 1994 Feb; 205(2):168-73. PubMed ID: 8108467
[TBL] [Abstract][Full Text] [Related]
13. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
Lebel N; D'Orléans-Juste P; Fournier A; Sirois P
Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361
[TBL] [Abstract][Full Text] [Related]
14. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
[TBL] [Abstract][Full Text] [Related]
15. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
Yap EY; Battistini B; McKay KO
Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition.
Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H
Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon.
Keller PM; Lee CP; Fenwick AE; Atkinson ST; Elliott JD; DeWolf WE
Biochem Biophys Res Commun; 1996 Jun; 223(2):372-8. PubMed ID: 8670289
[TBL] [Abstract][Full Text] [Related]
18. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of biological actions of big endothelin-1 by phosphoramidon.
Fukuroda T; Noguchi K; Tsuchida S; Nishikibe M; Ikemoto F; Okada K; Yano M
Biochem Biophys Res Commun; 1990 Oct; 172(2):390-5. PubMed ID: 2241940
[TBL] [Abstract][Full Text] [Related]
20. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
